Analyticon Biotechnologies 代理

详细介绍

产品咨询

世界*实验材料供应商Analyticon Biotechnologie正式上海金畔为其中国代理，Analyticon Biotechnologie 在一直是行业的*,一直为广大科研客户提供zui为优质的产品和服务,上海金畔一直秉承为中国科研客户带来的产品，的服务， Analyticon Biotechnologie 就是为了给广大科研客户带来更加完善的产品和服务,您的满意将是我们zui大的收获

Analyticon Biotechnologie 中国代理，Analyticon Biotechnologie 上海代理，Analyticon Biotechnologie北京代理， Analyticon Biotechnologie 广东代理，Analyticon Biotechnologie 江苏代理 Analyticon Biotechnologie 湖北代理, Analyticon Biotechnologie 天津, Analyticon Biotechnologie 黑龙江代理, Analyticon Biotechnologie内蒙古代理, Analyticon Biotechnologie 吉林代理, Analyticon Biotechnologie 福建代理, Analyticon Biotechnologie 江苏代理, Analyticon Biotechnologie 浙江代理, Analyticon Biotechnologie 四川代理,

德国Analyticon Biotechnologies  www.analyticon-diagnostics.com
Analyticon® Biotechnologies AG manufactures tests for human medical diagnosis, with approx. 83 employees in two facilities in the North of Hesse in Germany.

Our philosophy:
„Standard for highest Quality“ 
has caught on also outside Germany:

Based on a worldwide network of dealers and branch offices, we are distributing our products all over the world, meeting the requirements of the German Medical Product Law and the RiliBÄK as well as the standards of the US Food and Drug Administration (FDA) and the Chinese inspectorate SFDA.

All Products are manufactured in line with the GMP and DIN ISO 13 485 rules. We guarantee for a complete quality control, covering development, production and sales.

Analyticon®´s R&D continuously expands its product portfolio and at the same time keeps the quality of its IVD product offer at the highest level by regular product enhancements and perfective maintenance. The main activities are in line with Analyticon®´s core competence in the field of rapid tests which are focussing on the development of new point of care tests (POCTs) for their use by medical professionals and POCTs for self-/home testing, as strips and dipsticks. The envisaged biomarkers cover a broad range of clinical applications:

Pregnancy tests 
Ovulation tests 
Diabetes 
Cardiac markers 
Tumor markers 
Infectious diseases 
Drugs of abuse tests

The tests under development are based on a proprietary methodology using synthetic nucleic acids or other comparable docking molecules as highly specific binders for individual biomarkers which act as molecular switches depending on the presence or absence of the respective marker molecule. This methodology, for which Analyticon® has filed patent, promises technical and economic advantages for POCT tests compared to the products that are currently available in the IVD market without accepting any compromise in the quality. A further benefit of the methodology is its modular concept which simplifies the assay development for new biomarkers. Diagnostical test systems based on synthetic nucleic acids have also potential to serve as basis for a therapeutic approach in the corresponding disease area. In parallel, so-called fast-track specific binders are used in the short-term programs. Since most of the POCT assays are developed in solution in the first step, Analyticon® also expects to establish the corresponding clinical chemistry tests in parallel for some of the biomarkers.
 

上海金畔生物科技有限公司